US Imaging for the Assessment of LUTS
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18-80
SponsorUniversity of Wisconsin, Madison
About this trial
The purpose of this research is to develop an ultrasound (US) based urodynamics (UDS) evaluation of voiding based on successful magnetic resonance imaging (MRI)-UDS evaluation. Both US and MRI are non-invasive imaging techniques, but US is a more cost-effective and widely available technology. 80 participants will be enrolled and will be on study for up to 2.5 hours (1.5 hour MRI and 1 hour US).
Eligibility criteria
Qualifiers
Age 18-80 years old
Diagnosed with BPH/LUTS with or without obstruction
Disqualifiers
Patients with contraindication to MRI and/or GBCA contrast agent. Diabetic subjects will not receive contrast.
History of overt neurologic disease other than diabetic neuropathy, urinary tract infection within the last 4 weeks or recent history of urinary retention (within the last 4 weeks).
Patients with contraindication to MRI and/or GBCA contrast agent.
Currently taking medications with known effects on the bladder, overt neurologic disease other than diabetic neuropathy, urinary tract infection within the last 4 weeks or urinary retention symptoms.
Trial design
Treatments tested in this trial
- MRI-UDS; US-UDS; MCUD
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Wisconsin, Madison
Lead sponsor
Wisconsin Partnership Program
Collaborator
Source ClinicalTrials.gov